A detailed history of Versant Capital Management, Inc transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 238 shares of LNTH stock, worth $19,239. This represents 0.01% of its overall portfolio holdings.

Number of Shares
238
Previous 238 -0.0%
Holding current value
$19,239
Previous $19,000 36.84%
% of portfolio
0.01%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024

SELL
$55.6 - $77.89 $1,000 - $1,402
-18 Reduced 7.03%
238 $14,000
Q3 2023

Oct 11, 2023

SELL
$60.27 - $90.75 $1,747 - $2,631
-29 Reduced 10.18%
256 $17,000
Q2 2023

Jul 10, 2023

SELL
$82.41 - $99.65 $659 - $797
-8 Reduced 2.73%
285 $23,000
Q1 2023

Apr 10, 2023

SELL
$47.76 - $82.86 $2,674 - $4,640
-56 Reduced 16.05%
293 $24,000
Q4 2022

Jan 25, 2023

SELL
$48.76 - $77.67 $14,189 - $22,601
-291 Reduced 45.47%
349 $0
Q3 2022

Dec 30, 2022

SELL
$61.42 - $86.29 $307 - $431
-5 Reduced 0.78%
640 $45,000
Q2 2022

Aug 02, 2022

SELL
$55.54 - $72.65 $444 - $581
-8 Reduced 1.23%
645 $43,000
Q1 2022

Apr 29, 2022

SELL
$24.28 - $56.64 $4,710 - $10,988
-194 Reduced 22.9%
653 $36,000
Q2 2021

Jul 22, 2021

BUY
$19.51 - $27.64 $4,467 - $6,329
229 Added 37.06%
847 $23,000
Q1 2021

Apr 27, 2021

BUY
$13.77 - $21.66 $3,800 - $5,978
276 Added 80.7%
618 $13,000
Q4 2020

Feb 08, 2021

BUY
$10.75 - $14.91 $204 - $283
19 Added 5.88%
342 $4,000
Q3 2020

Nov 02, 2020

SELL
$11.98 - $16.34 $7,523 - $10,261
-628 Reduced 66.04%
323 $4,000
Q2 2020

Jul 16, 2020

BUY
$10.34 - $15.51 $4,590 - $6,886
444 Added 87.57%
951 $13,000
Q1 2020

Apr 17, 2020

BUY
$9.11 - $20.05 $4,618 - $10,165
507 New
507 $6,000
Q4 2019

Jan 28, 2020

SELL
$18.47 - $24.03 $277 - $360
-15 Closed
0 $0
Q1 2019

Apr 23, 2019

BUY
$14.93 - $25.1 $223 - $376
15 New
15 $0
Q1 2019

Apr 23, 2019

BUY
$14.93 - $25.1 $0 - $0
0 New
0 $0

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.56B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.